Kochanny; Monica J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kochanny; Monica J..The latest application filed is for "diamine derivatives as inhibitors of leukotriene a4 hydrolase".

Company Profile

1.16.11

Kochanny; Monica J. - Benicia CA
Kochanny; Monica J - Benicia CA US
Kochanny; Monica J. - San Rafael CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Diamine derivatives as inhibitors of leukotriene A4 hydrolase Grant 11,267,819 - Arnaiz , et al. March 8, 2	2022-03-08
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20200308181 - Arnaiz; Damian O. ; et al.	2020-10-01
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20180230159 - Arnaiz; Damian O. ; et al.	2018-08-16
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20160272649 - Arnaiz; Damian O. ; et al.	2016-09-22
Diamine derivatives as inhibitors of leukotriene A4 hydrolase Grant 9,315,509 - Arnaiz , et al. April 19, 2	2016-04-19
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20150080382 - Arnaiz; Damian O. ; et al.	2015-03-19
Diamine derivatives as inhibitors of leukotriene A4 hydrolase Grant 8,569,303 - Arnaiz , et al. October 29, 2	2013-10-29
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20130123243 - Arnaiz; Damian O. ; et al.	2013-05-16
Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase App 20100210630 - Arnaiz; Damian ; et al.	2010-08-19
Diamine derivatives as inhibitors of leukotriene A.sub.4 hydrolase Grant 7,737,145 - Arnaiz , et al. June 15, 2	2010-06-15
Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents Grant 7,504,410 - Bryant , et al. March 17, 2	2009-03-17
Diamine derivatives as inhibitors of leukotriene A4 hydrolase App 20070155726 - Arnaiz; Damian ; et al.	2007-07-05
Amide inhibitors of leukotriene A4 hydrolase App 20070155727 - Chen; Ming ; et al.	2007-07-05
Substituted quinoline CCR5 receptor antagonists Grant 7,220,856 - Dunning , et al. May 22, 2	2007-05-22
Piperidine derivatives and their use as anti-inflammatory agents App 20060167044 - Arnaiz; Damian O. ; et al.	2006-07-27
Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents App 20040186118 - Bryant, Judi ; et al.	2004-09-23
Substituted quinoline CCR5 receptor antagonists App 20040072818 - Dunning, Laura ; et al.	2004-04-15
Ortho-anthranilamide derivatives as anti-coagulants Grant 6,498,185 - Arnaiz , et al. December 24, 2	2002-12-24
Ortho-anthranilamide derivatives as anti-coagulants Grant 6,380,221 - Arnaiz , et al. April 30, 2	2002-04-30
Thio acid derived monocyclic N-heterocyclics as anticoagulants Grant 6,221,886 - Kochanny , et al. April 24, 2	2001-04-24
Thio acid derived monocyclic N-heterocyclics as anticoagulants Grant 6,166,014 - Kochanny , et al. December 26, 2	2000-12-26
Thio acid derived monocyclic N-heterocyclics as anticoagulants Grant 6,162,807 - Kochanny , et al. December 19, 2	2000-12-19
Thio acid derived monocyclic n-heterocyclics as anticoagulants Grant 6,150,382 - Kochanny , et al. November 21, 2	2000-11-21
Ortho-anthranilamide derivatives as anti-coagulants Grant 6,140,351 - Arnaiz , et al. October 31, 2	2000-10-31
Thio acid derived monocyclic N-heterocyclics as anticoagulants Grant 6,034,084 - Kochanny , et al. March 7, 2	2000-03-07
Thio acid derived monocylic N-heterocyclics as anticoagulants Grant 6,004,985 - Kochanny , et al. December 21, 1	1999-12-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.